PubMed Health⌕ Search

PubMed · 9390850

Co-oximetry.

Abstract

The adequacy of tissue oxygenation depends on the interaction of many factors. Assuming the presence of sufficient tissue perfusion, oxygenation failure must be caused by depressed respiratory efficiency (shunt or other ventilation/perfusion mismatch), inadequate FIO2/PaO2 relationships (alveolar-capillary diffusion deficits, for example), or oxygen transport difficulties (hemoglobin loading/unloading dysfunction). When presented with patients whose respiratory distress is not alleviated by application of increasing levels of FIO2 and seemingly adequate SaO2 values, one must look toward less obvious reasons for the disparity between subjective and objective findings. Early response by clinicians to situations such as those just mentioned should include a survey and analysis of hemoglobin status. It is important to note that meaningful co-oximetry results depend on the quality of the patient history and other laboratory tests to rule out factors that might affect the co-oximetry results. Good preparation of the sample is essential to ensure that adequate hemolysis has occurred and that the sample was not contaminated prior to analysis. A well designed and executed program of preventive maintenance and QA is important. It should include preparation and sampling as well as technique and instrument integrity. All of these are essential for safe, effective, and accurate determination and dissemination of this important clinical information.

Explore related subjects

Keep this discovery

Explore connections, maps & timelines

BibTeXRIS

P J Mathews. 1995. Co-oximetry.. https://pubmed.ncbi.nlm.nih.gov/9390850/

Cite the original work for its findings. Save a collection to share your selection of sources.

KEEP EXPLORING

Related citations

Global Genomic Surveillance.

Global genomic surveillance has emerged as a foundational pillar of public health in the twenty-first century, enabling real-time tracking of pathogen evolution and informing outbreak response. This chapter examines the strategic architecture of global genomic surveillance, focusing on its application to arboviruses such as chikungunya virus (CHIKV). It explores the integration of genomic data with epidemiological, clinical, and environmental information within a One Health framework, while addressing critical challenges in governance, equity, and interoperability. The discussion covers the entire genomic surveillance workflow, from sample collection and sequencing to bioinformatic analysis and phylogenetic inference, and highlights the transformative role of artificial intelligence (AI) in predictive surveillance. By analyzing global initiatives, operational barriers, and emerging technologies, this chapter underscores the necessity of sustainable, equitable, and interoperable genomic systems to proactively address current and future infectious disease threats.

Humans↗

Systematic Dissection of Key Driver Perturbation Signatures in Single Cells via ECCITE-seq.

CRISPR screens, such as expanded CRISPR-compatible cellular indexing of transcriptomes and epitopes by sequencing (ECCITE-seq), enable the simultaneous measurement of transcriptomes, gRNA identity, and cell-surface protein expression at single-cell resolution to systematically interrogate gene function. This platform provides a powerful and scalable experimental approach for validating disease-associated regulators identified by large-scale association studies and other computational methods, including network-based analyses of multi-omics data. Here, as an example application, we describe an ECCITE-seq framework to characterize the transcriptomic consequences of perturbing multiple neuronal key driver genes associated with Alzheimer's disease (AD) in human-induced pluripotent stem cell (hiPSC)-derived neurons. More broadly, by integrating customized pooled gRNA libraries with different CRISPR effectors across multiple cell types, this approach allows for the assessment of the regulatory impact of candidate genes implicated in development and disease processes.

Humans↗

Identification of Genome-Wide Chromatin Structural Aberration in Cancer by Hi-C Analysis.

Aberrant three-dimensional genome organization is a hallmark of cancer, often driving oncogene activation through mechanisms such as enhancer hijacking. High-throughput chromosome conformation capture (Hi-C) maps these interactions on a genome-wide scale. Unlike earlier dilution-based methods, in situ Hi-C performs proximity ligation within intact nuclei, minimizing random ligation noise and enabling fine-scale structure detection. This chapter describes an optimized in situ Hi-C protocol tailored for cancer cell lines using MboI digestion and biotin-mediated pull-down to generate high-complexity libraries. We further outline a computational workflow that extends beyond standard topological mapping of compartments and topologically associating domains to identify cancer-specific aberrations. Specifically, we focus on detecting chromosomal rearrangements (structural variants) and characterizing the distinct circular topology of extrachromosomal DNA. This integrated experimental and analytical framework provides the necessary tools to dissect the spatial dysregulation underlying tumor evolution.

Humans↗